MR-Guided Transurethral Ultrasound Ablation (TULSA)-An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.
Kin Fen Kevin FungRoberto Luigi CazzatoThibault TricardPierre D E MariniGregory BertucciPierre-Alexis AutrusseauGuillaume KochJulia WeissJulien GarnonHervé LangAfshin GangiPublished in: Cardiovascular and interventional radiology (2024)
The optimal treatment strategy for men with localised prostatic cancer of low and intermediate risk is an actively evolving field. It is important to strike a balance between maximal oncological control and minimal treatment-related complications, which helps preserve the patients' quality of life. MR-guided transurethral ultrasound ablation (TULSA) has emerged as a minimally invasive treatment option for this group of patients. This article aims to provide of a background on TULSA technology, a step-by-step procedural guide of MR-guided TULSA and to summarise the current evidence of TULSA in management of localised prostatic cancer, as well as other potential indications.
Keyphrases
- prostate cancer
- minimally invasive
- end stage renal disease
- magnetic resonance imaging
- radical prostatectomy
- newly diagnosed
- chronic kidney disease
- benign prostatic hyperplasia
- prognostic factors
- young adults
- computed tomography
- risk factors
- combination therapy
- ultrasound guided
- blood pressure
- atrial fibrillation
- smoking cessation
- childhood cancer